• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光化性角化病单独治疗的有效性和耐受性:冷冻疗法、CO2 激光和 5%氟尿嘧啶/10%水杨酸之间的回顾性比较

Effectiveness and tolerability of treatment for isolated actinic keratoses: A retrospective comparison between cryotherapy, CO laser and 5-fluorouracil 0.5%/salicylic acid 10.

机构信息

Dermatology Clinic, Maggiore Hospital of Trieste, Trieste, Italy.

Department of Clinical and Experimental Medicine, Dermatology, University of Messina, Messina, Italy.

出版信息

Dermatol Ther. 2021 Mar;34(2):e14846. doi: 10.1111/dth.14846. Epub 2021 Feb 16.

DOI:10.1111/dth.14846
PMID:33528869
Abstract

Actinic keratoses (AK) have been described as either intraepithelial keratinocytic dysplasia that can evolve into invasive squamous cell carcinoma (SCC) or as in situ SCC that can progress into an invasive form. A retrospective study was conducted to compare outcomes of three different topical therapies for patients with single AK (<4): cryotherapy, CO laser and 5-fluorouracil 0.5%/salicylic acid 10%. We included 72 patients who presented at the Dermatology Clinic of Maggiore Hospital of Trieste between 1 November 2019 and 31 January 2020 for the treatment of AKs. All treatments led to a significant reduction in the average diameter of AK. Pain felt by patients was significantly lower after 5-FU 0.5%/SA 10%. Side effects appeared similarly distributed among the three groups, with erythema and crusts being the most frequent. Aesthetic outcomes were highest in the 5-FU 5%/SA 10% group, as evaluated by both the patient and the operator. Cryotherapy, CO laser and 5-FU 5%/SA 10% were all effective, with no significant efficacy differences among them. Additionally, 5-FU 5%/SA 10% was proved to have the best aesthetic result and to cause the least pain, while necessitating long-term administration. This should be taken into account for patients with low pain tolerance and low treatment adherence. Cryotherapy and CO laser have the advantage of requiring a single session, which might be more suitable for uncooperative patients.

摘要

光化性角化病 (AK) 被描述为上皮内角质形成细胞异型增生,可进展为侵袭性鳞状细胞癌 (SCC),或原位 SCC 可进展为侵袭性形式。一项回顾性研究比较了三种不同的局部治疗单一 AK(<4)患者的结果:冷冻疗法、CO2 激光和 5-氟尿嘧啶 0.5%/水杨酸 10%。我们纳入了 2019 年 11 月 1 日至 2020 年 1 月 31 日期间在的里雅斯特马焦雷医院皮肤科诊所就诊的 72 例 AK 患者。所有治疗均显著降低 AK 的平均直径。与 CO2 激光和冷冻疗法相比,5-FU 0.5%/SA 10%治疗后患者的疼痛明显减轻。三种治疗方法的不良反应发生率相似,以红斑和结痂最为常见。5-FU 0.5%/SA 10%组的美学效果最高,患者和操作者均给予高度评价。冷冻疗法、CO2 激光和 5-FU 0.5%/SA 10%均有效,疗效无显著差异。此外,5-FU 0.5%/SA 10%具有最佳的美学效果和最小的疼痛,需要长期治疗。这应考虑到低疼痛耐受度和低治疗依从性的患者。冷冻疗法和 CO2 激光单次治疗即可,可能更适合不合作的患者。

相似文献

1
Effectiveness and tolerability of treatment for isolated actinic keratoses: A retrospective comparison between cryotherapy, CO laser and 5-fluorouracil 0.5%/salicylic acid 10.光化性角化病单独治疗的有效性和耐受性:冷冻疗法、CO2 激光和 5%氟尿嘧啶/10%水杨酸之间的回顾性比较
Dermatol Ther. 2021 Mar;34(2):e14846. doi: 10.1111/dth.14846. Epub 2021 Feb 16.
2
Cost-effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain.西班牙5-氟尿嘧啶0.5%/水杨酸10%治疗光化性角化病的成本效益分析
Expert Rev Pharmacoecon Outcomes Res. 2015 Jun;15(3):539-43. doi: 10.1586/14737167.2015.995171. Epub 2014 Dec 13.
3
A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis.一项前瞻性随机探索性研究,比较每日一次外用0.5% 5-氟尿嘧啶联合10.0%水杨酸(5-FU/SA)与冷冻手术治疗角化过度性光化性角化病的疗效。
J Eur Acad Dermatol Venereol. 2015 May;29(5):881-9. doi: 10.1111/jdv.12702. Epub 2014 Sep 25.
4
Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.低剂量 5-氟尿嘧啶联合水杨酸作为一种新的皮损定向治疗外用光化性角化病的方法:组织学和临床研究结果。
Br J Dermatol. 2011 Nov;165(5):1101-8. doi: 10.1111/j.1365-2133.2011.10387.x.
5
Low-Dose 0.5% 5-Fluorouracil/10% Salicylic Acid Topical Solution in the Treatment of Actinic Keratoses.低剂量0.5% 5-氟尿嘧啶/10%水杨酸外用溶液治疗光化性角化病
J Cutan Med Surg. 2016 Nov;20(6):555-561. doi: 10.1177/1203475416659259. Epub 2016 Jul 21.
6
Low-dose 5-fluorouracil in combination with salicylic acid for the treatment of actinic keratoses on the hands and/or forearms - results of a non-interventional study.低剂量5-氟尿嘧啶联合水杨酸治疗手部和/或前臂光化性角化病——一项非干预性研究的结果
J Eur Acad Dermatol Venereol. 2017 Mar;31(3):455-462. doi: 10.1111/jdv.13935. Epub 2016 Sep 23.
7
Comparison of topical 5-fluorouracil formulations in actinic keratosis treatment.比较治疗光化性角化病的外用 5-氟尿嘧啶制剂。
J Dermatolog Treat. 2010 Sep;21(5):267-71. doi: 10.3109/09546630903341937.
8
Topical treatment of actinic keratoses with low-dose 5-fluorouracil in combination with salicylic acid--pilot study.低剂量 5-氟尿嘧啶联合水杨酸局部治疗光化性角化病——初步研究。
J Dtsch Dermatol Ges. 2010 Mar;8(3):174-8. doi: 10.1111/j.1610-0387.2009.07293.x. Epub 2009 Nov 2.
9
Actikerall™ (5-Fluorouracil 0.5% and Salicylic Acid 10%) Topical Solution for Patient-directed Treatment of Actinic Keratoses.艾克泰乳膏™(5-氟尿嘧啶0.5%和水杨酸10%)外用溶液,用于患者自行治疗光化性角化病。
Skin Therapy Lett. 2016 May;21(3):1-3.
10
Recurrence rates and patient assessed outcomes of 0.5% 5-fluorouracil in combination with salicylic acid treating actinic keratoses.0.5% 5-氟尿嘧啶联合水杨酸治疗光化性角化病的复发率和患者评估结果。
Eur J Dermatol. 2012 May-Jun;22(3):370-4. doi: 10.1684/ejd.2012.1707.

引用本文的文献

1
Role of Nicotinamide in the Pathogenesis of Actinic Keratosis: Implications for NAD/SIRT1 Pathway.烟酰胺在光化性角化病发病机制中的作用:对NAD/SIRT1途径的启示
Biomolecules. 2024 Nov 27;14(12):1512. doi: 10.3390/biom14121512.
2
Preliminary Evidence of Efficacy, Safety, and Treatment Satisfaction with Tirbanibulin 1% Ointment: A Clinical Perspective on Actinic Keratoses.1%替拉替尼软膏疗效、安全性及治疗满意度的初步证据:光化性角化病的临床视角
Pharmaceuticals (Basel). 2023 Dec 4;16(12):1686. doi: 10.3390/ph16121686.
3
Actinic Keratoses: A Prospective Pilot Study on a Novel Formulation of 4% 5-Fluorouracil Cream and a Review of Other Current Topical Treatment Options.
光化性角化病:一项关于4% 5-氟尿嘧啶乳膏新配方的前瞻性初步研究及其他当前局部治疗选择的综述
Cancers (Basel). 2023 May 28;15(11):2956. doi: 10.3390/cancers15112956.